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CRISPR-Cas mediated immunity in bacteria allows bacterial populations to protect themselves
against pathogens. However, it also exposes them to the dangers of auto-immunity by developing
protection that targets its own genome. Using a simple model of the coupled dynamics of phage
and bacterial populations, we explore how acquisition rates affect the survival rate of the bacterial
colony. We find that the optimal strategy depends on the initial population sizes of both viruses
and bacteria. Additionally, certain combinations of acquisition and dynamical rates and initial
population sizes guarantee protection, due to a dynamical balance between the evolving population
sizes, without relying on acquisition of viral spacers. Outside this regime, the high cost of auto-
immunity limits the acquisition rate. We discuss these optimal survival strategies in terms of recent
experiments.
I. INTRODUCTION
Organisms have developed a wide variety of strategies
to deal with pathogens [1–5]. Bacteria use immunity
both at the population level by adopting heterogenous
phenotypes with different susceptibility to varying envi-
ronments [6–9], as well as specific solutions that target
invading phage viruses [10–12]. These strategies involve
restriction enzymes that render the viral genetic mate-
rial unviable [10], and the CRISPR (Clustered Regularly
Interspaced Short Palindromic Repeats) Cas (CRISPR-
associated system of proteins) system [11, 12], which al-
lows bacterial lineages to develop memory about encoun-
tered pathogens and protect future generations.
The CRISPR-Cas mechanism consists of a machinery
of enzymes that integrates 20 to 50 base pair (bp) unique
viral DNA or RNA fragments, also called spacers, into the
CRISPR loci of the bacterial genome (see Figure 1A).
Upon expression, these spacer RNAs serve as a guide to
identify viral genomic material and target it for degra-
dation. Through its ability to constantly integrate new
genetic material, CRISPR-Cas provides bacteria with
adaptive immunity, which is heritable by offspring thanks
to its integration into the host genome [11, 12]. Addition-
ally to acquisition of new spacers, spacers can also be
lost. In fact, the distribution of diversity and abundance
of individual spacers in virally challenged bacterial pop-
ulations is highly variable [13–17]. Acquired spacers in
type I and II systems, which are the focus of this paper,
are not uniformly sampled from the viral genomes but
are chosen for excision by Cas proteins from fragments
adjacent to short (3-5 bp) regions called protospacer ad-
jacent motifs (PAM) [18]. While mechanisms for avoiding
targeting the CRISPR-Cas loci itself have been identified
[19], since PAM sequences are so short they can also be
found in other parts of the bacterial host’s own DNA and
acquire self-targeting spacers [20, 21] (see Figure 1B).
Additionally, self-targeting spacer related mortality has
been proposed as one of the major costs associated with
the CRISPR-Cas system [22–25].
A large body of theoretical work has focused on the
evolution of the spacer cassettes [26–29] and their di-
versity [13, 30–33]. These studies range from exploring
spacer distribution dynamics as a function of the param-
eters of the system such as the rates of spacer acquisi-
tion and loss and mutation rates, to more detailed ex-
planations of the spatial structure of spacer insertions.
Apart from its Lamarckian evolution aspect [34, 35], a
lot of models have studied the CRISPR-Cas system from
the point of view of bacterial-viral co-evolution and the
role of the ecological context [22, 36–38], with an empha-
sis on the cost of maintaining the CRISPR-Cas system
[22, 39, 40]. Studies have also focussed on other bacterial
defence strategies that play an important role, such as re-
striction modification enzymes [12, 41]. More recently,
aspects of CRISPR dynamics have been studied that in-
volve interactions between members of the population,
including communication between individual bacteria via
quorum sensing mechanisms [13].
The CRISPR-Cas system seems like an efficient im-
mune strategy, with evolutionary advantages particularly
for very rare pathogens [5]. However, it carries poten-
tial metabolic costs [40]. Additionally, similarly to other
specific immune systems, such as the adaptive immune
2system of vertebrates [42], it carries the potential risk of
autoimmunity [19, 23]. Specifically, in addition to inte-
grating the DNA of attacking viruses, it is not currently
clear how to prevent the bacterium from integrating its
own DNA into the CRISPR cassettes and then targeting
itself. Some evidence suggests that most of the acquisi-
tion is self-targeting when the interference part is turned
off [21]. This may be explained by cas9 and/or the cas
complexes that drive recognition, playing a role during
the acquisition process as suggested in the same article
[21, 43], or cas proteins being unable to distinguish self
versus non-self targeting spacers effectively. While bac-
terial immunity, even in controlled experiments, is not
limited to the CRISPR-Cas system, and involves the co-
evolution of the bacterial and phage populations, here
we focus only on the specific consequences of potentially
acquiring autoimmunity via self-spacer uptake on short
timescales. We ask how bacteria can survive, even in the
worst case scenario when the DNA acquisition machinery
is unbiased. We want to show that there is an optimal
way that bacteria may regulate acquisition, so that it
provides them with the largest protection against foreign
viruses, while minimizing the costs of self-targeting.
II. MODEL
We consider an environment with V copies of the virus,
and two types of bacterial cells (see Fig. 1 C): N – the
number of bacterial cells without spacers conferring pro-
tection against the virus, andNv – the number of immune
bacterial cells thanks to the presence of a specific spacer.
The total number of bacteria is Ntot = N +Nv. For sim-
plicity, we assume a single, constant viral strain, and we
do not model the spacer composition in detail. Spacer-
carrying bacteria survive encounters with the virus, while
susceptible bacteria do not unless an acquisition event
occurs. Both bacterial populations grow with a max-
imum growth rate f , but are limited by resources en-
coded by the carrying capacity K. Susceptible cells get
infected by the virus with rate J , infected cells die at
rate µ producing B copies of the virus. Infected cells
can also acquire spacers with rate η. The fraction of
spacers that are acquired from exogenous genetic mate-
rial is encoded by the parameter, β, which describes the
probability of non-self spacer acquisition, so that the rate
of exogenous spacer acquisition is βη. Bacteria also ac-
quire self-targeting spacers with an overall rate (1−β)η.
Within this model, the mean growth rate of viral cells
is given by bursting of infected cells that do not acquire
spacers. Viral cells decay with rate d. At the time
of infection, t = 0, the two viral and susceptible bacte-
rial populations are mixed together, with variable initial
sizes, N = N0, V = V0, and Nv = 0, and the system
evolves towards co-existence or the extinction of one or
more of the species involved.
The non-self spacer acquisition parameter β is assumed
to be small and set by constraints beyond bacteria’s con-
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FIG. 1: Cartoon representation of the CRISPR-Cas
system model. A. Bacteria protect themselves from sur-
rounding phage viruses, V , by up-taking segments of their
DNA and incorporating it into their genome. The up-
taken spacers (colored rectangles) are incorporated into the
CRISPR locus and separated by linkers (black diamonds). B.
A susceptible bacterium (empty oval) can take up viral DNA
spacers from the red phage (top) or its own DNA as spac-
ers from its own genome (bottom). The acquisition rate of
any new spacer is η. We note that we define our rates as
the proportionality constant to the number of individuals in
the reacting populations, as is customary in chemical kinet-
ics. Our rates have units of inverse time. C. In a given viral
environment, a number N of bacteria do not carry protection
and are phage susceptible (empty ovals), they can get infected
(empty ovals with viruses) and after acquisition bacteria be-
come resistant with the appropriate anti-phage spacers (col-
ored ovals). All bacteria reproduce at a maximum growth
rate f up to carrying capacity K. Susceptible bacteria be-
come infected with rate J or they acquire a self-targeting
spacer with rate η (since they are not infected they can only
acquire self-targetting spacers). Infected cells can acquire a
spacer with rate η and become resistant with probability β or
die due to autoimmunity from self-spacers. Infected cells that
do not acquire spacers die at a rate µ producing B new virus
copies. We assume there are two type of spacers: the self-
targeting spacers of bacterial origin, which lead to the death
of the bacteria through auto-immunity, and a proportion of
phage-targeting spacers up-taken with probability β, whose
incorporation turns susceptible bacteria into protected ones.
trol, such as the ratio of viral exogenous versus self ge-
netic material. In principle this assumption can be re-
laxed and β could depend on the multiplicity of infection
(MOI) – a quantity related to the ratio of bacterial ver-
sus viral genetic material in the cell. In this case, the
non-self and self-acquisition parameters are subject to a
feedback mechanism described by sigmoid functions. For
simplicity we assume that the infection starts at low MOI
so that β can be considered constant, which is a limiting
case of the fuller feedback model. On the other hand,
we assume that the acquisition rate of spacers, η, is reg-
ulated by the bacterial host population by phenotypic
adaptation or quorum sensing [44, 45]. We then ask how
a bacterial acquisition rate affects the long-term proba-
bility of bacterial survival.
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FIG. 2: Typical behavior of the bacterial-viral model. The left panels show the time evolution of the fraction of
bacterial species (green are the susceptible bacteria and yellow are the resistant bacteria), the number of bacteria and the
number of phage with parameters β = 0.01, K = 105, d = 0.2 hr−1 per phage and b = 10−3 hr−1 per phage, µ = 0.8 hr−1 per
cell, in three regimes: (A) bacteria go extinct (η = 0.001 hr−1 per cell, and initial conditions N0 = 500, V0 = ×10
4), (B) virus
goes extinct and bacteria are saved by immunity (η = 0.02 hr−1 per cell, and initial conditions N0 = 500, V0 = ×10
4), (C) virus
and bacteria co-exist oscillating and then acquisition happens at a stochastic time (η = 0.03 hr−1 per cell and initial conditions
N0 = 900, V0 = 6×10
4). (D) Phase-space diagram showing bacterial population as a function of phage population for β = 0.01
η = 0.005 hr−1 per cell for two initial conditions [900, 6 × 104] and [1100, 5 × 103] in the conservative case K ≫ Ntot. (E)
Phase-space diagram for the same parameters as in panel B in the non-conservative dynamics.
The set of reactions presented above and summarized
in Fig. 1 is the basis for a stochastic dynamical process, in
which the numbers of viruses, susceptible, infected and
non-susceptible bacteria evolve over time. An example
trace for the temporal change in the numbers of the par-
ticipating species shows that both bacteria and viruses
can go extinct. Starting from high initial viral numbers
and no immune bacteria, the number of susceptible bac-
teria decreases significantly, going extinct for some pa-
rameter values (Fig. 2A). However, if bacteria avoid ex-
tinction, the number of immune bacteria increases and
the viruses can lose their reproductive reservoir and go
extinct (Fig. 2B). In a third parameter regime, suscep-
tible bacteria and viruses can co-exist in stable oscilla-
tory dynamics (Fig. 2C) until immunity is acquired and
spreads throughout the bacterial population.
The process described above, before any viral spacer is
incorportated, is encoded in a set of ordinary differential
equations for the temporal evolution of the susceptible
and infected bacterial populations, and the viral popula-
tion
∂N
∂t
=
(
1−
N
K
)
fN − ηN − JV N
∂I
∂t
= JV N − ηI − µI,
∂V
∂t
= BµI − dV,
(1)
whereN is the number of cells in the susceptible bacterial
population, I is the number of cells in the infected bacte-
rial population, and V is the number of cells in the phage
population. Bacteria grow with a maximum growth rate
f , limited by the carrying capacity K. Bacteria get in-
fected with rate J and die due to self-spacer acquisition
with rate η (since we assumed no viral spacer acquisition
at this stage). The number of infected cells that are not
acquiring viral targeting spacers increases due to viral in-
fection and decreases with rate η due to acquisition and
µ due to cell bursting. The number of viruses grows due
to bursting of infected cells producing B new copies of
4the virus and decays with rate d. If we assume that the
time scale for bursting is much smaller than the timescale
of spacer acquisition, infected cells are in steady state,
I ≈ JV N/(η + µ). In this limit, equations 1 simplify to
1
N
∂N
∂t
=
(
1−
N
K
)
f − η − JV,
1
V
∂V
∂t
= (1 − η/µ)BJN − d,
(2)
Rescaling V by J , v = JV these equations simplify to:
1
N
∂N
∂t
=
(
1−
N
K
)
f − η − v,
1
v
∂v
∂t
= bN(1− η/µ)− d,
(3)
where b = BJ is the rescaled bursting factor.
These equations (Eqs. 2 and 3) are valid as long as
protected bacteria are completely absent, Nv = 0. When
acquisition, which is a random event, first occurs, the
bacterial population as a whole is likely to survive over
very long time scales, as the protected population will
displace the susceptible one and eventually drive the viral
population to extinction. This scenario, in which all three
species are coupled, is not described by Eq. 2, which only
models the pre-acquisition period. Thus, while N and V
are treated deterministically, Nv is treated stochastically
through the first time of acquisition, i.e. the time at
which Nv jumps from 0 to 1. At that point, we consider
the bacterial population safe. Clearly this is an approxi-
mation, which we discuss later.
The first acquisition event follows a Poisson point pro-
cess occurring with rate (β/µ)ηJV N , meaning that it
occurs with probability (β/µ)ηJV Ndt between times t
and t+dt. Thus the probability that no acquisition event
occurs before time t is:
P(t) = e−(β/µ)ηJ
∫
t
0
N(t)V (t)dt = e−(β/µ)η
∫
t
0
N(t)v(t)dt.
(4)
Before that event, the bacterial population may be driven
to very low concentrations by the virus, putting the full
colony at risk. We assume that this happens when the
susceptible bacteria numbers N reach some low popu-
lation size threshold Next. Within this model we are
not considering any other form of immunity. This ex-
tinction boundary is chosen in an arbitrary way to re-
flect the small size of a population near extinction and
to avoid explicitly treating the stochastic dynamics at
small copy numbers. By the term ‘avoiding extinction,’
we mean the possibility that susceptible bacteria survive
the small population size bottleneck just by chance. In
most of the laboratory experiments, bacteria never go ex-
tinct because they mutate and become resistant by other
mechanisms (restriction-modification mechanisms (RM)
or surface modification mutants (SM)) that we do not
consider. Here we do not compare different types of im-
munity but address the question of whether the CRISPR-
Cas can be beneficial, despite self-targeting. The time
text at which extinction occurs is determined by the so-
lution to the deterministic equation Eq. 3 (text can take
a value of +∞ if the threshold is never reached, see be-
low). In this formulation and within these approxima-
tions, the bacterial population will survive if and only if
an acquisition event occurs before extinction, with prob-
ability Psurv = 1−Pext = 1−P(text). In the special case
where no extinction occurs even in the absence of any
acquisition, text =∞, we obtain Psurv = 1.
To gain some intuition, we first describe the pre-
acquisition dynamics in the limit of small bacterial sizes,
N ≪ K, where Eq. 3 can be integrated analytically. In
that limit, the term N/K drops from Eq. 3, which re-
duces to the well-studied Lokta-Volterra equations [46–
49]. This approximation is justified if we are interested
in small, vulnerable bacterial populations which are far
from the limits imposed by their carrying capacity. As
is already known [46, 47, 49], Lotka–Volterra equations
admit a conserved quantity, which is constant over time:
L = (f − η) ln v(t) + d lnN(t)− v(t)− b(1− η/µ)N(t).
(5)
This conserved quantity implies that the dynamics in
the (N, v) phase space follows a closed counterclock-
wise orbit around the fixed point at v∗ = f − η and
N∗ = d/b(1− η/µ) (Fig. 2D). The orbit is set by the val-
ues of the initial viral and susceptible populations and
the model parameters, which determine L once and for
all. Small orbits that stay close to the fixed point will
not hit the extinction boundary Next. The set of initial
conditions falling into these orbits defines a ‘safe zone’, in
which the bacterial population is guaranteed to survive.
The critical value L0 of the conserved quantity separat-
ing safe from extinction orbits is obtained by considering
the critical orbit hitting the extinction boundary tangen-
tially, so that N = Next and dN/dt = 0, which implies
v = v∗ = f − η and thus L0 = L(Next, f − η). Orbits
with L > L0 will be safe, while orbits with L < L0 will
go extinct unless an acquisition event occurs. Initial con-
ditions that are close to the fixed point belong to safe
orbits, while either very small of very large initial viral
and bacterial populations may lead to extinction.
The general, non-conservative dynamics (Eq. 3) with
finite K behave similarly, with the difference that the
orbits become spirals converging counterclockwise to the
fixed point (see Fig. 2E). The spirals circle inwards to-
ward the fixed point N∗ = d/b(1−η/µ), v∗ = (1−d/b(1−
η/µ)K)f − η, unless they hit the extinction boundary
Next first. Along the way, a susceptible bacteria may ac-
quire a protective spacer. As in the conservative case,
the probability of survival depends on the initial sizes of
the viral and bacterial populations in two ways. Firstly,
the longer the trajectory, the larger the probability of
acquiring a spacer. Secondly, certain initial conditions
ensure that the trajectory never reaches the extinction
threshold defining a safe zone, just as in the conservative
case. However, belonging to the safe zone can no longer
be associated to the value of a conserved quantity.
5This basic qualitative analysis points to the impor-
tance of the initial conditions for the probability of sur-
vival. While this may seem as a problematic artefact of
the model, recent experiments have reported that bac-
terial survival rates in controlled environments depend
on the initial concentration ratios of phages and bacte-
ria [22]. This observation was driven by theoretical work
that explored the limiting role of environmental resources
on the choice between inducible and constitutive mech-
anisms [50, 51]. Specifically, WT Pseudomas aeruginosa
bacteria grown in 104, 107 and 109 plaque forming units
(pfu) of non-targeted phage (NTφ) showed a large de-
crease in the fraction of bacteria that acquired CRISPR-
Cas mediated immunity in populations with large phage
exposure (Fig. 3A in Ref. [22]). Keeping the same num-
ber of infecting phages but increasing the flask size to de-
crease the phage density resulted in a higher fraction of
bacteria that acquired CRISPR-Cas mediated immunity
in populations with low phage density exposure (Fig. 3B
in Ref. [22]). In the same experiments, opposite trends
were reported for constitutive immunity quantified in
terms of the loss of the phage receptor (surface modi-
fication mediated resistance). These results were linked
to the costs of the two different protection modes. We
have not included an alternative mechanism of defence
so we can not directly compare our results to these ex-
periments. However, these experimental results suggest
that the likelihood of using CRISPR-Cas mediated im-
munity show a dependence on the initial phage exposure
concentrations. Additionally, a new series of experiments
[44, 45] show a dependence of cas-expression levels on cell
density, suggesting that bacteria might be able to effec-
tively regulate their acquisition rate.
III. RESULTS
We first analyze the dependence on initial population
sizes. For a fixed small value of the spacer acquisition rate
η = 0.1 hr−1 and fixed growth and degradation rates, we
explore the probability of survival as a function of the ini-
tial phage exposure and the initial size of the susceptible
bacteria population [52]. We calculate the probability of
extinction, defined as Pext = P(text) using Eq. 4. The
results are shown in Fig. 3 as a function of the initial
population sizes, N0 and V0.
As predicted from the phase space argument of Fig. 2E,
a safe zone around the fixed point emerges for initial
conditions that ensures that the trajectory never hits the
extinction boundary (in white). The boundary of the safe
zone (black line) can be calculated by integrating the
dynamical equations (Eq. 3) backwards from the point
of the critical trajectory that is tangent to the extinction
boundary, N = Next, and dN/dt = 0, i.e. v = (1 −
Next/K)f − η.
Within the safe zone, survival is ensured because the
trajectory never reaches extinction, and instead reaches
the fixed point (red point) even in absence of acquisition,
FIG. 3: Probability of extinction for a fixed value of
the acquisition rate η = 0.1 hr−1, as function of the ini-
tial population sizes.. The phase diagram represents the
probability of extinction calculated using the coupled deter-
ministic dynamics of Eq. 2, and Eq. 4. The probability of ex-
tinction is defined as the probability of not acquiring a protec-
tion before reaching the extinction boundary N = Next = 10.
The white area is the set of initial conditions that define the
safe zone: dynamics starting from these points will never hit
the extinction boundary and instead spiral counterclockwise
into the fixed point. The gray diamonds A-D mark particular
examples of initial conditions discussed in detail in Fig. 4.
The orange line marks the safe zone for another value of
η = 0.45 hr−1. Parameters of the dynamics: f = 0.5 hr−1 per
cell, K = 106, β = 0.01, J = 10−5 hr−1 per cell per phage,
η = 0.1 hr−1 per cell, B = 100, µ = 0.8 hr−1 per phage
and d = 0.2 hr−1 per phage. The concentrations are given in
terms of mean numbers of individuals.
giving the bacterial population unlimited time to uptake
a protective spacer. The safe zone is centered around the
stable fixed point with a larger spread in initial bacterial
population sizes (two decades for the chosen parameters)
than initial phage population sizes (one decade for the
chosen parameters).
Outside the safe zone, very large initial viral popula-
tion sizes lead to rapid extinction of the bacterial pop-
ulation, with little chance of acquiring a spacer (yellow
region). Perhaps less intuitively, very large initial bacte-
rial populations strongly facilitate initial phage growth,
leading to high-amplitude dynamics and host extinction
in absence of acquisition. This effect sets the rightmost
border of the safe zone. In that regime however, there
is enough time and opportunity to allow for the acquisi-
tion of protection, as can be seen from the low extinction
probabilities. Likewise, small initial phage populations
lead to dynamics outside the safe zone, but with a suffi-
cient time for spacer acquisition, as the dynamics spiral
counterclockwise around the fixed point (Fig. 2E). As a
result, a broad region of initial conditions under the safe
zone ensures near-certain survival (blue region).
Crucially, the safe zone and extinction probabilities de-
6pend on the value of the acquisition rate, η. In Fig. 3 we
plotted, on top the results for η = 0.1 hr−1, the bound-
ary of the safe zone for a different value of the acquisition
rate, η = 0.45 hr−1, to illustrate how that zone can dra-
matically vary. Changing β, however, does not change
the boundaries of the safe zone but simply rescales the
logarithm of the extinction probability by a constant fac-
tor (Eq. 4), only affecting the values of the contours in
Fig. 3.
Despite increasing (on a logarithmic scale) the size of
the safe zone as well as the probability to acquire pro-
tection, very large η values are not always the optimal
strategy for survival. Depending on the initial bacterial
and viral population sizes, the optimal acquisition rate
that maximizes the survival probability varies dramati-
cally (Fig. 4). We calculated the survival probability as
a function of the acquisition rate η (scaled by the growth
rate f) for four choices of initial conditions marked by
gray diamonds in Fig. 3. Since η is an effective degrada-
tion rate for the susceptible bacterial population, η values
larger than the maximal growth rate f lead to population
collapse, limiting η/f between 0 and 1.
For initial conditions that position the two populations
away from the safe zone for all values of η, putting the
susceptible population on an extinction course (point A
in Fig. 3), an intermediate value of η is optimal for bac-
terial survival (Fig. 4A). In this regime survival crucially
depends on acquiring a protective spacer from the virus.
Too small acquisition rates make it unlikely that any
spacer is taken up during the spiral integration period.
Conversely, too large acquisition rates increase the prob-
ability of up-taking a self-targeting spacer, which in our
model leads to bacterial death and thus to a faster ex-
tinction. This tradeoff results in an intermediate value
of η.
For small initial viral population sizes and small initial
bacterial population sizes (point B in Fig. 3), the dy-
namics fall into the safe zone for large acquisition rates
(Fig. 4B). In this case, although there is still an opti-
mal acquisition rate outside the safe zone, the optimal
strategy is not to rely on luck but to choose a very large
acquisition rate that will stabilize the dynamics towards
the fixed point, ensuring population survival.
Note that this regime corresponds to small initial viral
population sizes, since the safe zone encompasses these
initial conditions only for large η: in general, the safe
zone is centered around the fixed point and v∗ = f − η,
so that the safe zone extends to smaller initial viral pop-
ulation sizes as the rate of acquisition increases η → f .
Intuitively, large acquisition rates are needed to rapidly
degrade the bacterial population and maintain the Lotka-
Volterra-like stability.
Conversely, systems with large initial viral population
sizes (point C in Fig. 3) find themselves in the safe zone
only for small η values (Fig. 4C). In this case, small ef-
fective degradation rates keep the bacterial population
relatively large and stable compared to the viral popu-
lation. In this parameter regime, the optimal strategy
consists of minimizing spacer acquisition to increase fit-
ness.
Lastly, for intermediate initial viral population sizes
(point D in Fig. 3), deterministic dynamics are
extinction-free for intermediate η values (Fig. 4D). Ef-
fectively, we recover the situation in Fig. 4A, where an
intermediate acquisition rate is optimal, albeit for a dif-
ferent reason. In Fig. 4A the bacterial population in-
creases its survival probability by stochastically acquir-
ing non-self targeting spacers. However the probability
of extinction remains non-zero and the bacteria are never
truly safe. For the initial condition parameter regime in
Fig. 4D, the bacteria will never go extinct with interme-
diate acquisition rates, simply due to the deterministic
Lotka-Volterra-like dynamics [53]. By having different
η and fitness, bacteria control the coupled dynamics so
as to keep their population size away from extinction.
In this case, the acquisition of protective spacers is not
essential, similarly to the cases of Fig. 4B and C.
Clearly, having acquisition rates such as to fall into
the safe zone is the best strategy the bacterial popula-
tion can adopt, since it guarantees certain survival. From
Fig. 4 we see that the range of η values that guarantee
survival is larger or smaller, depending on the different
initial population sizes. Additionally, in certain cases the
safe zone is not accessible. We can summarize the discus-
sion of Fig. 4 by two phase diagrams: one that shows the
width of the range of acquisition rates that position the
system in the safe zone (Fig. 5A), and one that shows the
optimal acquisition rate for initial population sizes where
the safe zone is not available (Fig. 5B), along with the ex-
tinction probability thus achieved (Fig. 5C). Moderately
large initial viral populations ensure non-extinction dy-
namics for a broad choice of acquisition rates, and for
a wide range of initial bacterial population sizes. The
range of η values that guarantee safe dynamics shrinks
with decreasing initial viral population sizes, and be-
comes confined to a narrower range of initial bacterial
population sizes. This result reflects the compatibility
requirement between viral and bacterial populations in
the Lotka-Volterra dynamics. The acquisition rate has
the role of an effective death term that limits the growth
of the bacterial population, in turn limiting viral expan-
sion, and controlling the amplitude of oscillations around
the fixed point. If the Lotka-Volterra-like balance is bro-
ken, fluctuations become large, and the dynamics leaves
the safe zone (Fig. 5B). In that case, bacteria rely on
stochastically acquiring spacers for survival. For very
high initial viral population sizes, the susceptible bacteria
find themselves in the kamikaze regime: they are largely
out-numbered so the best strategy is to take up as much
DNA as they can, not worrying about the drawbacks of
auto-immunity. In any case, as we see from Fig. 3, in
this regime their chance of survival is extremely small.
For smaller initial viral population sizes, the danger of
auto-immunity kicks in and optimal strategies rely on
intermediate η values, as described in Fig. 4A.
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FIG. 4: The probability of extinction as a function of η shows 4 distinct regimes. Panels A-D correspond to the
different values of the initial conditions denoted by gray points in Fig. 3. A) For initial conditions outside the safe zone for all
η, the dynamics always hit the extinction boundary regardless of the value of the aquisition rate. The extinction probability is
minimized at intermediate values of η realizing a trade-off between the cost and benefit of acquisition. B) The initial conditions
are safe (i.e. lead to dynamics reaching the fixed point without ever hitting the extinction boundary) for large η values; C)
The initial conditions are safe for small η values; D) The initial conditions are safe for intermediate η values. Parameters of the
dynamics: K = 106, J = 10−5 hr−1 per cell per phage, f = 0.5 hr−1 per cell, d = 0.2 hr−1 per phage, β = 0.001, µ = 0.8 hr−1
per cell. Initial conditions (from A to D): N0 = (1500, 200, 600, 1100), V0 = (10
4, 10, 105, 7 · 104).
/f
FIG. 5: Phase diagrams of the optimal survival strategies. (A) Range of acquisition rates η that position the system
in the safe zone, as a function of initial virus and bacteria population sizes. The range is defined as the width of the region of
η values where the extinction probability is strictly zero in Fig. 4B-D. The initial conditions of points A-D presented in Fig. 4
are shown as grey dots. (B) Optimal acquisition rate normalized by the growth rate f for initial population sizes where the
safe zone is not available as a function of initial virus and bacteria population sizes. The optimal acquisition rate is defined
as the minimum of the probability of extinction in Fig. 4A. (C) Probability of extinction associated to the optimal rate. In B
and C the white area corresponds to zero extinction probability. Parameters: K = 106, f = 0.5 hr−1 per cell, d = 0.2 hr−1 per
phage, β = 0.01 and µ = 0.8 hr−1 per cell. The concentrations are given in terms of mean numbers of individuals.
IV. DISCUSSION
The general question of the efficiency of CRISPR-
Cas mediated immunity has already been extensively ex-
plored [22, 34, 50, 51]. Our approach focuses on how
regulating the spacer acquisition rate affects the sur-
vival probability of bacterial populations. Specifically,
we were interested in the dangers of auto-immunity stem-
ming from acquiring self-targeting spacers [20, 21]. This
danger becomes larger for large acquisition rates and our
simple model does show that it is often best for bacterial
survival to avoid very large acquisition rates. However,
the straightforward argument of wanting to avoid self-
acquisition while still targeting phages works only in a
limited range of initial phage and bacterial population
sizes. For many systems, survival is insured by a de-
terministic Lotka-Volterra-like dynamics that keeps the
two co-evolving population sizes balanced so that neither
grows too large. Having an acquisition rate η to an op-
timal value for survival within this model means having
an initial condition that is positioned in this safe zone
regime, where deterministic Lotka-Volterra-like dynam-
ics guarantees convergence to the fixed point, rather than
having to rely on a stochastic acquisition event.
8Nevertheless, for certain values of initial population
sizes, no value of η guarantees certain survival and in
these regimes avoiding auto-immunity becomes impor-
tant. For most initial population sizes in this regime
there exists an optimal intermediate value of the acqui-
sition rate that results in a non-zero survival probability,
and prevents the whole population being killed by both
phages and auto-immunity. Only for very large initial
phage populations is the optimal acquisition rate close to
the maximum possible value of the maximal growth rate.
In this case however, even this optimal choice of η fails
to substantially ensure survival. However, as previous
theory and experiments have shown [5, 22], in the regime
of high phage density and large exposure, constitutive
immune strategies such as surface modification mediated
immunity are more common than CRISPR-Cas mediated
immunity. In our analysis, we have not introduced any
other forms of immunity since we wanted to focus only
on how CRISPR-Cas self-acquisition affects the survival
rate. For this reason we cannot directly compare our
results to these experiments [22]. However, the poor sur-
vival rate of the CRSIPR-Cas system predicted by our
model in the regime of high initial density is not incon-
sistent with experimental results, although the source of
the poor survival in the experiment and in the model
is likely to be very different. To explore this origin we
would need to model receptor resistance explicitly. Our
results do however second the theoretical idea [5] that
constitutive immunity is a better strategy for very large
phage populations.
We assumed that the acquisition rate is a param-
eter the bacterial population can regulate, since bac-
teria make the decision to uptake or not uptake for-
eign DNA by turning on their adaptive form of immu-
nity [22, 44, 45]. On the other hand we assumed that
modifying β – the probability of up-taking non self-
targeting DNA, as opposed to self DNA – is much harder
[20, 21]. In principle, one can imagine that on evolu-
tionary timescales β can be modified by mutating PAM
motifs. However the timescales for this are much longer
than the phenotypic modification of modifying η, and this
strategy has limited benefits due to the short lengths of
PAM motifs. It would interesting in the future to explore
dynamics that lead to the optimal value of the acquisi-
tion rate η, and/or allow it to be controlled accurately.
However, we do not explore this issue in this work.
Experimental studies have both reported the unbiased
acquisition of self-targeting spacers from the bacterial
genome compared to viral DNA [21] (the low observed
frequency of self spacers being is due to the elimination
of self-targeting bacteria), and identified mechanisms for
preferential acquisition of viral spacers [20] (at stalled
replication forks which are more common in phages, and
away from Chi sites which are more common in bacteria).
Since the acquisition rates in our model are effective, we
can change them and explore both limits. Our results
are compatible with both of these scenarios. When in-
creasing the value of β, we observe that the probability
of extinction goes to zero exponentially fast with a char-
acteristic value ηc ≪ f . This means that a small value
of η ensures almost perfect survival from the infection
and a maximum growth rate very similar to the wild
type that is consistent with the results that a functional
CRISPR-Cas mechanism do not change much the fitness
in competition experiments in absence of the phage.
Recent studies have shown that bacteria in both P.
aeruginosa and Serratia can tune the use of CRISPR-
Cas mediated immunity by communicating with other
bacteria in the population so that the population level
immune defense is coordinated [44, 45]. The coordina-
tion is achieved through quorum sensing pathways and
leads to an increase in the expression of Cas proteins
at high bacterial cell density. Cas proteins are directly
involved in spacer acquisition, so having different Cas
protein concentrations is a direct way of having different
acquisition rates. A theoretical model showed that regu-
lating the CRISPR-Cas system in a density dependent
way, leads to phenotypic bistability in the population
[13]: CRISPR-Cas immunity is up-regulated at high bac-
terial density and down-regulated at low bacterial den-
sity. The two ecologically different states differ both by
their bacteria to phage ratio and by their spacer diversity
composition. Quorum sensing introduces an additional
feedback mechanism into our model, whose effects need
to be studied in more detail. In the monostable regime,
this feedback simply renormalizes the acquisition rate. In
the bistable regime, it may lead to a more complicated
form of the phase diagram but it is unlikely to change the
general conclusion about the existence of a safe zone and
a regime where the acquisition rate matters. Addition-
ally, it would be interesting to consider a more detailed
model that predicts the spacer diversity distribution in
the safe zone compared to the acquisition zone. This
would provide a means of directly comparing our results
to experiments.
Our results also show that in general up-taking spacers
is a good survival strategy. We identified a set of initial
population sizes where η can be strictly equal to zero.
Small η is the optimal strategy for a small range of ini-
tial conditions. Even if a large fraction of bacteria will
die from self-targeted spacers, acquiring DNA is still a
good population level survival strategy. However, if the
CRISPR-Cas is able to discriminate self versus non-self,
meaning that the probability of acquiring self-targeting
spacers is low, then a small value of acquisition rate η
is enough to ensure almost perfect survival rate of the
colony. Thus in this regime, the regulation of acquisition
rate is not under selective pressure.
Experiments show that Cas protein expression, which
is an essential part of acquiring new spacers, is the most
costly element of maintaining the CRISPR-Cas type II-
A system in Streptococcus thermophilus [40]. Cas pro-
tein expression reduces fitness, and Cas-deficient mutants
achieve higher fitness in competition experiments against
WT strains, in contrast to experiments with the type I-F
CRISPR-Cas system of P. aeruginosa, where knocking
9out a cas gene had little effect on its competitive growth
rate with respect to the WT strain [22]. The growth
rate reduction in S. thermophilus seem to also depend
on phage exposure [40], but no significant fitness costs
were identified associated with launching the CRISPR-
Cas immune system. Once the CRISPR-Cas system is in
place, acquiring spacers does not seem to hold additional
costs besides auto-immunity.
Following recent work [13], our model stresses the im-
portance of population level approaches. It is important
that the susceptible bacterial population survives and not
particular individuals. However, the model we consider is
simple and we make a number of approximations. First
of all, we treat extinction deterministically: either the
bacterial population will go extinct if it reaches small
numbers at the Next = 10 boundary, or it will survive. In
reality, the dynamics at small population sizes is stochas-
tic and extinction only happens at N = 0. Even a bacte-
rial population that descends to small numbers can still
grow and increase over the arbitrarily chosen determin-
istic threshold, by means of stochastic dynamics. Con-
versely, even during the safe deterministic trajectory we
can imagine an accumulation of rare acquisition events
of self-targeting spacers that will lead the population to
extinction. Considering a full stochastic model will likely
make quantitative differences but it is unlikely to change
the qualitative conclusions. We also assumed that once
there is a first phage targeting acquisition event, the pop-
ulation is sure to survive. However, the lineage carrying
the protection could still go extinct due to the stochas-
tic nature of division and death. Taking this effect into
account would simply renormalize the probability of for-
eign spacer acquisition β, which is an effective parameter
of our model, and would not affect our conclusions.
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